SecBot SecBot
SECBOTREPLAY Home › Report › ARQT

ARQT · Three insiders at Arcutis Biotherapeutics sold a total of $198K in…

Arcutis Biotherapeutics, Inc. · CLUSTER filed Aug 24, 2026 at 16:19 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Aug 24, 2026 at 16:19 ET

Three insiders at Arcutis Biotherapeutics sold a total of $198K in open-market sales over a 7-day window, with the largest sale ($124K) by Director Howard Welgus. The total value is only ~0.006% of the company's $3.2B market cap, making this a trivial cluster by proportionality. No cross-filing context suggests distress or material negative news; the cluster is neutral and low-impact.

  • Three insiders sold shares totaling $198K in open-market sales from Aug 13-20, 2026.
  • Total sales represent only ~0.006% of Arcutis's $3.2B market cap, well below the 0.1% materiality threshold.
  • Director Howard Welgus accounted for the largest sale at $124K; Director Terrie Curran also exercised non-cash derivatives.
  • No cross-filing context indicates distress, earnings miss, or material negative news.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access